The global Pessary Market is projected to experience robust growth, expanding from an estimated USD 422.9 million in 2025 to USD 1117.0 million by 2035, reflecting a compound annual growth rate (CAGR) of 10.2% over the forecast period, according to industry analysis by Future Market Insights.
This surge is fueled by increasing awareness of pelvic organ prolapse (POP), urinary incontinence, and postnatal complications, particularly among the aging female population. With more women seeking non-surgical alternatives, pessary devices are emerging as a critical first-line therapy, offering affordable, effective, and less invasive treatment options.
Key Market Insights
- Market Value (2025): USD 422.9 million
- Forecast Value (2035): USD 1117.0 million
- Forecast CAGR (2025–2035): 10.2%
- Leading Type Segment (2025): Gellhorn pessary (48.7%)
- Top End-Use Segment (2025): Hospitals (53.2%)
- High-Growth Regions: North America, Asia-Pacific, Europe
Industry Trends and Growth Drivers
Shift Toward Non-Surgical Treatment Options:
The Fourth International Consultation on Incontinence recommends pessaries, pelvic floor muscle training, and lifestyle modifications as conservative management strategies for women with POP. With nearly 50% of women aged 50–80 affected by some form of prolapse, pessaries are increasingly recognized as a safe and effective solution.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/pessary-market
Technological Advancements:
The integration of AI-driven design and 3D modeling is enabling companies like Femtherapeutics Inc. to create customized pessary devices, reducing discomfort and improving long-term patient outcomes. Similarly, Liv Labs has launched a reusable, over-the-counter pessary, broadening access to non-prescription options.
Hospital Dominance in End-Use:
Hospitals account for over 53% of pessary adoption due to skilled practitioners, advanced diagnostic tools, and structured patient follow-up protocols. Integration into outpatient care and rehabilitation services further strengthens this segment.
Rise of Biocompatible Materials:
The transition to medical-grade silicone and other biocompatible materials has improved durability, reduced infection risks, and enhanced patient comfort. These innovations are expected to accelerate adoption across clinical settings.
Competitive Benchmarking
The global pessary market remains highly competitive, with major players including:
- MedGyn Products, Inc.
- Cooper Surgical Inc.
- Personal Medical Corp.
- Panpac Medical Corp.
- Smiths Medical
- Thomas Medical
- Bioteque America, Inc.
- Integra LifeSciences Corporation
- Dr. Arabin GmbH & Co.
- Wallach Surgical Devices
Recent moves underscore consolidation and innovation:
- CooperCompanies announced a USD 875 million acquisition of Cook Medical’s Reproductive Health division in February 2025, reinforcing its leadership in non-invasive gynecology devices.
- Theramex expanded its partnership with Endoceutics to commercialize Intrarosa in Australia, diversifying women’s health offerings.
- Liv Labs introduced a prescription-free, reusable pessary, redefining accessibility for women managing incontinence.
These strategic initiatives signal a trend toward product diversification and patient-centric design, aligning with global demand for minimally invasive solutions.
Regional Outlook
- North America: Expected to hold over 35% of global market share, driven by an aging population and high POP surgery rates (approximately 200,000 procedures annually in the U.S.).
- Asia Pacific: Forecasted to deliver double-digit growth, led by Japan, China, and India. Rising awareness, medical tourism, and UN-backed health programs are catalyzing adoption.
- Europe: Supported by clinical guidelines, particularly the UK Clinical Guideline for Pessary Use, which promotes best practices among healthcare professionals.
Get Sample Report: – https://www.futuremarketinsights.com/reports/sample/rep-gb-15899
Market Opportunities
- Ring pessaries are forecasted to grow at 11% CAGR, driven by ease of use and suitability for early-stage POP.
- The hospital segment is projected to expand at 11.4% CAGR, fueled by rising post-operative demand and insurance coverage.
- Advancements in personalized medicine and home-based pessary solutions present untapped growth potential in developed and emerging markets alike.
Analyst Perspective
“The pessary market is at a pivotal stage where technological innovation meets clinical necessity. With women’s health receiving greater global attention, and healthcare providers prioritizing conservative management approaches, pessaries are well-positioned to become mainstream in gynecological care,” said [Analyst Name], [Position], Future Market Insights.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
